0
0
Home » Pharmaceuticals

Indonesia Healthcare, Regulatory and Reimbursement Landscape – CountryFocus

GlobalData, the industry analysis specialist, has released its latest report, “Indonesia Healthcare, Regulatory and Reimbursement Landscape – CountryFocus”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Indonesia. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

Indonesia’s pharmaceutical market value in terms of Indonesian rupiah was worth Rp47,600B in 2012, which increased at a CAGR of 9% to Rp67,200B in 2016. However, the pharmaceutical market value in terms of US dollars was $5.08B in 2012, which decreased at a negative CAGR of 0.15% to $5.05B in 2016. The market value is expected to decrease further to $5.0B by 2023. The pharmaceutical market value is attributed to growing population, the universal health coverage scheme, improved macroeconomic conditions, and the government's support for pharmaceuticals and medical device industry development. However, currency fluctuation is the barrier to increasing Indonesian pharmaceutical market.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Indonesia, and includes:

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

Profiles and SWOT analyses of the major players in the pharmaceutical market: Kalbe, Sanbe, SOHO, Daewoong, and Novartis

An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices

Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure

An overview of the opportunities for and challenges to growth in the Indonesia healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to:

Develop business strategies by understanding the trends shaping and driving Indonesia’s healthcare market

Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Indonesia’s healthcare market in the future

Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance

Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

Table of Contents

1 Table of Contents

1.1 List of Figures

1.2 List of Tables

2 Executive Summary

2.1 Executive Summary – Overview-

2.2 Key Highlights

2.3 Key Highlights: Healthcare Start-Ups in Indonesia

2.4 Key Events: Indonesia Healthcare History, 2014-2020

2.5 Key Events: Indonesia Pharmaceutical Market

2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-2020

2.7 Key Events: Mergers and Acquisitions

2.8 Country Profile, Indonesia, 2019

3 Overview of Pharmaceutical Market

3.1 Pharmaceutical Market – Overview

3.2 Pharmaceutical Market – Exports

3.3 Pharmaceutical Market – Imports

3.4 Pharmaceutical Market – Supply Channels, Indonesia

3.5 Pharmaceutical Market – Market Segments

3.6 Pharmaceutical Market – Non-communicable Disease Mortality, Indonesia

3.7 COVID-19 Epidemiology, Indonesia

3.8 Government Response to Mitigate COVID-19, Indonesia

3.9 COVID-19 Impact and Developments in Healthcare Market, Indonesia

3.10 Pharmaceutical Market – Major Players

4 Overview of Medical Devices Market

4.1 Medical Device Market – Overview

5 Pharmaceutical and Medical Device Market – Drivers and Barriers

5.1 Drivers

5.2 Barriers

6 Deal analysis

6.1 Deal Analysis: M&A, VC, and PE Deals, Pharmaceutical Market, Indonesia 2019-2020

7 HealthTech Landscape

7.1 HealthTech Landscape, Indonesia

7.2 Key HealthTech Deals, Indonesia

7.3 Adoption of Technology in Healthcare, Indonesia

7.4 Key Developments: Technology in Healthcare, Indonesia

7.5 Regulatory Scenario on the Use of Technology in Healthcare, Indonesia

7.6 HealthTech Landscape – Benefits and Risks, Indonesia

8 Market Access

8.1 Overview of Healthcare System, Indonesia

8.2 Reimbursement of Medicinal Products, Indonesia

8.3 Overview of Public Insurance Providers, Indonesia

8.4 Overview of Private Insurance Providers, Indonesia

8.5 Healthcare Spending and Health Price Index, Indonesia

8.6 Pricing Policies, Indonesia

8.7 Regulatory Landscape, Indonesia

8.7.1 Overview of Regulatory Agencies, Indonesia

8.7.2 Market Authorization for Pharmaceutical Drugs, Indonesia

8.7.3 Market Authorization for Medical Devices, Indonesia

8.7.4 Intellectual Property Rights, Indonesia

8.7.5 Intellectual Property Rights, Patent, Indonesia

8.7.6 Intellectual Property Rights, Trademark, Indonesia

8.7.7 Pharmaceutical Clinical Trials Landscape, Indonesia

8.7.8 COVID-19 Clinical Trials Landscape, Indonesia

8.7.9 Clinical Trial Regulations, Indonesia

8.7.10 Export and Import Regulations, Indonesia

8.7.11 Pharmaceutical Advertising Regulations, Indonesia

8.7.12 Labeling and Packaging Regulations, Indonesia

9 Country Healthcare Landscape

9.1 Indonesian Healthcare Policy Highlights

9.2 Healthcare Facilities, Indonesia

9.3 Healthcare Parameters, Indonesia

9.4 Life Expectancy and Immunization Rate, Indonesia

9.5 Environmental Health, Indonesia

9.6 Healthcare Personnel, Indonesia

9.7 Disease Burden, Indonesia

9.8 Healthcare Expenditure, Indonesia

10 Trade Associations, Indonesia

11 Trade Fairs, Indonesia

12 Opportunities and Challenges

13 Appendix

13.1 Research Methodology

13.1.1 Coverage

13.1.2 Secondary Research

13.1.3 Forecasts

13.1.4 Expert Panel

13.2 Bibliography

13.3 Contact Us

13.4 Disclaimer

List of Tables

Table 1: Mortality Rate of Non-communicable Diseases, Indonesia, 2018

Table 2: COVID-19 Indicators (Number of cases), Global and Indonesia, 2020

Table 3: COVID-19 IVD Products, Indonesia, 2020

Table 4: Drug Registration fees, Indonesia, 2027

Table 5: Fees For Medical Devices Registration, Indonesia

Table 6: Patent Registration Fees, Indonesia, 2016

Table 7: Trademark Registration Fees, Indonesia, 2020

Table 8: Summary of Product Characteristics, Indonesia

Table 9: Pharmaceutical Label, Indonesia, 2017

List of Figures

Figure 1: Pharmaceutical Market, Indonesia, Revenue ($B), 2012-2018

Figure 2: OTC Market, Indonesia, Revenue ($B), 2012-2018

Figure 3: Healthcare Startups in Indonesia, 2020

Figure 4: Number of Deals (2019-2020)

Figure 5: 2019-2020 Deal Overview by Region

Figure 6: Country Profile, Indonesia, 2019

Figure 7: Pharmaceutical Market, Indonesia, Revenue ($B), 2012-2018

Figure 8: Pharmaceutical Market, Indonesia, Revenue Forecast ($B), 2019-2023

Figure 9: Pharmaceutical Exports ($B), Indonesia, 2012-2018

Figure 10: Top Export Partners, Indonesia, 2018

Figure 11: Pharmaceutical Imports ($B), Indonesia, 2012-2018

Figure 12: Top Import Partners, Indonesia, 2018

Figure 13: Pharmaceutical Market, Supply Chain, Indonesia

Figure 14: T-test for Stagnant and Stock Out Condition, Indonesia, 2019

Figure 15: OTC Market, Indonesia, Revenue ($B), 2012-2018

Figure 16: OTC Market by Drug Category, Indonesia, Revenue ($M), 2018

Figure 17: Mortality Rate of Non-communicable Diseases, Indonesia, 2018

Figure 18: COVID-19 (Number of cases), Indonesia, 2020

Figure 19: COVID-19 (Number of deaths), Indonesia, 2020

Figure 20: Medical Devices Market, Indonesia, Revenue ($B), 2016-2019

Figure 21: Deal Value and Deal Count, Pharmaceutical Market, Indonesia, 2019-2020

Figure 22: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Indonesia, 2019-2020

Figure 23: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Indonesia, 2019-2020

Figure 24: Top Five Therapy Areas by Deal Value, Pharmaceutical Market, Indonesia, 2019-2020

Figure 25: M&A Deals by Therapy Area, Pharmaceutical Market, Indonesia, 2019-2020 (by Value)

Figure 26: Top Five Therapy Areas by Deal Number, Pharmaceutical Market, Indonesia, 2019-2020

Figure 27: Deal Value ($M), HealthTech, Indonesia, 2019-2020

Figure 28: Deal Count ($M), HealthTech, Indonesia, 2019-2020

Figure 29: Overview of Healthcare System, Indonesia, 2017

Figure 30: Addition of Drug to the Formulary, Indonesia, 2018

Figure 31: JKN Population Coverage (million), Indonesia, 2020

Figure 32: JKN Health Facilities, Indonesia, 2020

Figure 33: OOP Expenditure (% of total expenditure on health), Indonesia, 2012-2016

Figure 34: Annual Rate of Change (%), Health Price Index, Indonesia, 2012-2019

Figure 35: NADFC Organizational Structure, Indonesia, 2020

Figure 36: Drug Registration Process, Indonesia, 2020

Figure 37: Medical Devices Registration Process, Indonesia

Figure 38: Organizational Structure of DGIP, Indonesia, 2020

Figure 39: Patent Approval Process, Indonesia

Figure 40: Trademark Approval Process, Indonesia, 2020

Figure 41: Pharmaceutical Clinical Trials Count By Trial Status, Indonesia, 2019-2020

Figure 42: Pharmaceutical Clinical Trials Count By Phase, Indonesia, 2019-2020

Figure 43: Pharmaceutical Clinical Trials Count By Indication, Indonesia, 2019-2020

Figure 44: Top Five Pharmaceutical Clinical Trials Sponsors By Count, Indonesia, 2019-2020

Figure 45: COVID-19 Clinical Trials Count By Trial Status, Indonesia, 2019-2020

Figure 46: COVID-19 Clinical Trials Count by Phase, Indonesia, 2019-2020

Figure 47: Top Five COVID-19 Clinical Trials Sponsors by Count, Indonesia, 2019-2020

Figure 48: Pre-marketing Clinical Trial Approval , Indonesia

Figure 49: Post-marketing Clinical Trial Approval , Indonesia

Figure 50: Hospital Number, Indonesia, 2012-2018

Figure 51: Hospitals by Class, Indonesia, 2018

Figure 52: General Hospital Beds (number), Indonesia, 2012-2018

Figure 53: Specialized Hospital Beds (number), Indonesia, 2012-2018

Figure 54: Total Hospital Beds (per 1,000 Population), Indonesia, 2012-2018

Figure 55: Life Expectancy at Birth, Indonesia, 2012-2018

Figure 56: Immunization Rate (%), Indonesia, 2012-2018

Figure 57: PM2.5 (µg per m3), Indonesia, 2012-2018

Figure 58: CO2 Emissions (Million of Tons), Indonesia, 2012-2017

Figure 59: Physicians (per 1,000 Population), Indonesia, 2013-2018

Figure 60: Dentists (per 1,000 Population), Indonesia, 2013-2018

Figure 61: Pharmacists (per 1,000 Population), Indonesia, 2013-2018

Figure 62: Nurses (per 1,000 Population), Indonesia, 2013-2018

Figure 63: Major Causes of Mortality (number of deaths), Indonesia, 2016

Figure 64: Major Causes of Male Mortality (number of deaths), Indonesia, 2016

Figure 65: Major Causes of Female Mortality (number of deaths), Indonesia, 2016

Figure 66: Disability-Adjusted Life Years by Major Disease (thousands), Indonesia, 2016

Figure 67: Healthcare Expenditure as Percentage of GDP(%), Indonesia, 2012-2017

Figure 68: Public-Private Share (%), Indonesia, 2012-2017

Figure 69: Major Components of Healthcare Spending (%), Indonesia, 2018

Figure 70: PM2.5 (µg per m3), Indonesia, 2012-2018

Figure 71: CO2 Emissions (Million of Tons), Indonesia, 2012-2017

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2960

Join our mailing list

Saved reports